YJY-S Jia

Y-S Jia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Y-S Jia has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • C-X Bai

    Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Orthopaed, Beijing, Peoples R China

    1 shared publication
  • C-Y Zheng

    Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Orthopaed, Beijing, Peoples R China

    1 shared publication
  • Chen-Ying Zheng

    The First Department of Orthopaedics, Dongzhimen Hospital, Bejing University of Traditional Chinese Medicine, Beijing 100700, China

    1 shared publication
  • Cheng Ma

    The First Department of Orthopaedics, Dongzhimen Hospital, Bejing University of Traditional Chinese Medicine, Beijing 100700, China

    1 shared publication
  • Chun-Xiao Bai

    The First Department of Orthopaedics, Dongzhimen Hospital, Bejing University of Traditional Chinese Medicine, Beijing 100700, China

    1 shared publication
  • J-Y Li

    Department of Orthopaedics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.

    1 shared publication

Latest Publications

  • MicroRNA-449b-5p promotes the progression of osteoporosis by onhibiting osteogenic differentiation of BMSCs via targeting Satb2

    by J-Y Li, X. Wei, Q. Sun, X-Q Zhao, C-Y Zheng, C-X Bai, J. Du, Z. Zhang, L-G Zhu, Y-S Jia

    OBJECTIVE: We aimed to explore the role of microRNA-449b-5p in osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) and its mechanism of action. MATERIALS AND METHODS: Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) assay was used to detect the expression levels of microRNA-449b-5p and osteogenic markers including RUNX2. OCN during BMSCs differentiation. The microRNA-449b-5p mimic and microRNA-449b-5p inhibitors were transfected into BMSCs to achieve microRNA-449b-5p overexpression and knockdown, then the expressions of osteogenic markers were detected by qRT-PCR. The ALP activity staining and the alizarin red staining were used to detect the activity of ALP and the mineralization ability of cells after overexpression and knockdown of microRNA-449b-5p. Binding sites for microRNA-449b-5p and Satb2 were predicted by TargetScan, the PicTar and microRNA and a programs, and confirmed by dual-luciferase reporter gene assay. The relationship between microRNA-449b-5p and Satb2 was analyzed by QRT-PCR and Western blot. The microRNA-449b-5p inhibitor and shSATB2 lentivirus were simultaneously transfected in BMSCs, and the expression levels of RUNX2, OCN and ALP were detected by qRT-PCR and ALP activity assays. RESULTS: microRNA-449b-5p expression gradually decreased during osteogenic differentiation. Overexpression of microRNA-449b-5p inhibited BMSCs differentiation by down-regulating ALP activity, RUNX2, and OCN expression, while the opposite result was observed after knockdown of microRNA-449b-5p. MicroRNA-449b-5p can bind to the 3'UTR end of Satb2, which was involved in the osteogenic differentiation of microRNA-449b-5p-regulated BMSCs, and silencing of Satb2 can abolish the positive effect of the microRNA-449b-5p inhibitor on osteoblasts differentiation. CONCLUSIONS: microRNA-449b-5p could aggravate osteoporosis by inhibiting osteogenic differentiation of BMSCs through targeting Satb2.


    • 25 August 2018
      • Vol. 31  (8) , 751-756

    [Effect of Bryan cervical disc replacement on cervical curvature and replacement segment in treating cervical spondylosis].

    by Jin-Yu Li, Yu-Song Jia, Chen-Ying Zheng, Qi Sun, Jiang Chen, Chun-Xiao Bai, Li Du, Cheng Ma, Lin Xu

    To investigate the effect of Bryan cervical disc replacement on cervical curvature and replacement segment in the treatment of cervical spondylosis, and analyze its clinical efficacy. Forty-nine patients underwent Bryan artificial cervical disc replacement from August 2010 to August 2013 were retrospectively analyzed. There were 26 males and 23 females, aged from 27 to 66 years old with an average of 48.5 years. Including 21 cases of nerve root type, 16 cases of spinal cord type, 12 cases of mixed type. And 21 cases were single segment replacement, 28 cases were double segments replacement. Preoperative and postoperative pain was compared using visual analogue scale(VAS);cervical function was observed by Japanese Orthopedic Association Scores (JOA) and Neck Disability Index (NDI);cervical lordosis curvature, function spinal unit(FSU) curvature, activities of replacement and adjacent segment, FSU activity were measured by cervical X-rays. Clinical effects were evaluated by the Odom method. All the patients were followed up for 18.5 to 37.3 months with an average of 33.1 months. Pvoperative VAS, JOA, NDI scores were 7.08±1.55, 5.2±1.9, 39.96±7.06 before operation, 3.76±2.33, 13.20±1.20, 25.20±6.64 at 3 months after operation, and 2.80±1.50, 14.3±1.6, 24.24±7.89 at the last follow-up. Patients at three months and the last follow-up after operation were obviously improved in their VAS, JOA, and NDI scores (P0.05). Pharyngeal discomfort and hoarseness occurred in 5 cases, and were recovered within 2 weeks after operation;heterotopic ossification occurred in 1 case at 6 months after operation;displacement of prosthesis occurred in 1 case at 12 months after operation. Based on Odom standard to evaluate the clinical outcome, 20 cases obtained excellent results, with 27 good, 2 general. Bryan artificial cervical disc replacement not only generate good clinical effects, but may also restore the cervical lordosis and FSU curvature, while retaining the activities of replacement segment, and restoring overall cervical biomechanical functions.